OBJECTIVE: The incidence of invasive methicillin-resistant Staphylococcus aureus (MRSA) infections in the United States decreased during 2005-2008, but noninvasive community-associated MRSA (CA-MRSA) infections also frequently lead to hospitalization. We estimated the incidence of all MRSA infections among inpatients at US academic medical centers (AMCs) per 1,000 admissions during 2003-2008. DESIGN: Retrospective cohort study. SETTING AND PARTICIPANTS: Hospitalized patients at 90% of nonprofit US AMCs during 2003-2008. METHODS: Administrative data on MRSA infections from a hospital discharge database (University HealthSystem Consortium [UHC]) were adjusted for underreporting of the MRSA V09.0 International Classification of Diseases, Ninth Revision, Clinical Modification code and validated using chart reviews for patients with known MRSA infections in 2004-2005, 2006, and 2007. RESULTS: The mean sensitivity of administrative data for MRSA infections at the University of Chicago Medical Center in three 12-month periods during 2004-2007 was 59.1%. On the basis of estimates of billing data sensitivity from the literature and the University of Chicago Medical Center, the number of MRSA infections per 1,000 hospital discharges at US AMCs increased from 20.9 (range, 11.1-47.7) in 2003 to 41.7 (range, 21.9-94.0) in 2008. At the University of Chicago Medical Center, among infections cultured more than 3 days prior to hospital discharge, CA-MRSA infections were more likely to be captured in the UHC billing-derived data than were healthcare-associated MRSA infections. CONCLUSIONS: The number of hospital admissions for any MRSA infection per 1,000 hospital admissions overall increased during 2003-2008. Use of unadjusted administrative hospital discharge data or surveillance for invasive disease far underestimates the number of MRSA infections among hospitalized patients.
OBJECTIVE: The incidence of invasive methicillin-resistant Staphylococcus aureus (MRSA) infections in the United States decreased during 2005-2008, but noninvasive community-associated MRSA (CA-MRSA) infections also frequently lead to hospitalization. We estimated the incidence of all MRSA infections among inpatients at US academic medical centers (AMCs) per 1,000 admissions during 2003-2008. DESIGN: Retrospective cohort study. SETTING AND PARTICIPANTS: Hospitalized patients at 90% of nonprofit US AMCs during 2003-2008. METHODS: Administrative data on MRSA infections from a hospital discharge database (University HealthSystem Consortium [UHC]) were adjusted for underreporting of the MRSA V09.0 International Classification of Diseases, Ninth Revision, Clinical Modification code and validated using chart reviews for patients with known MRSA infections in 2004-2005, 2006, and 2007. RESULTS: The mean sensitivity of administrative data for MRSA infections at the University of Chicago Medical Center in three 12-month periods during 2004-2007 was 59.1%. On the basis of estimates of billing data sensitivity from the literature and the University of Chicago Medical Center, the number of MRSA infections per 1,000 hospital discharges at US AMCs increased from 20.9 (range, 11.1-47.7) in 2003 to 41.7 (range, 21.9-94.0) in 2008. At the University of Chicago Medical Center, among infections cultured more than 3 days prior to hospital discharge, CA-MRSA infections were more likely to be captured in the UHC billing-derived data than were healthcare-associated MRSA infections. CONCLUSIONS: The number of hospital admissions for any MRSA infection per 1,000 hospital admissions overall increased during 2003-2008. Use of unadjusted administrative hospital discharge data or surveillance for invasive disease far underestimates the number of MRSA infections among hospitalized patients.
Authors: Chunliu Zhan; Anne Elixhauser; Chesley L Richards; Yun Wang; William B Baine; Michael Pineau; Nancy Verzier; Rebecca Kliman; David Hunt Journal: Med Care Date: 2009-03 Impact factor: 2.983
Authors: Lucy A Wibbenmeyer; Gerald P Kealey; Barbara A Latenser; Daniel J Diekema; Ingrid M Williams; Stacy L Coffman; Patricia L Winokur; Jennifer S Kroeger; Robert W Lewis; Loreen A Herwaldt Journal: J Burn Care Res Date: 2008 Sep-Oct Impact factor: 1.845
Authors: Michael Z David; Daniel Glikman; Susan E Crawford; Jie Peng; Kimberly J King; Mark A Hostetler; Susan Boyle-Vavra; Robert S Daum Journal: J Infect Dis Date: 2008-05-01 Impact factor: 5.226
Authors: Thea Chua; Carol L Moore; Mary B Perri; Susan M Donabedian; William Masch; Dora Vager; Susan L Davis; Kaitlin Lulek; Benjamin Zimnicki; Marcus J Zervos Journal: J Clin Microbiol Date: 2008-05-28 Impact factor: 5.948
Authors: Cynthia L Maree; Robert S Daum; Susan Boyle-Vavra; Kelli Matayoshi; Loren G Miller Journal: Emerg Infect Dis Date: 2007-02 Impact factor: 6.883
Authors: Brian L Cheng; Travis B Nielsen; Paul Pantapalangkoor; Fan Zhao; Jean C Lee; Christopher P Montgomery; Brian Luna; Brad Spellberg; Robert S Daum Journal: Hum Vaccin Immunother Date: 2017-04-19 Impact factor: 3.452
Authors: Ashley N Rose; Paula Clogher; Kelly M Hatfield; Runa H Gokhale; Isaac See; Susan Petit Journal: Infect Control Hosp Epidemiol Date: 2020-06 Impact factor: 3.254
Authors: Erica S Shenoy; Hang Lee; Taige Hou; Winston Ware; Erin E Ryan; David C Hooper; Rochelle P Walensky Journal: Infect Control Hosp Epidemiol Date: 2016-03-29 Impact factor: 3.254
Authors: A de Breij; T G Karnaoukh; J Schrumpf; P S Hiemstra; P H Nibbering; J T van Dissel; P C de Visser Journal: Eur J Clin Microbiol Infect Dis Date: 2016-01-15 Impact factor: 3.267
Authors: Michael S Calderwood; Christopher A Desjardins; George Sakoulas; Robert Nicol; Andrea Dubois; Mary L Delaney; Ken Kleinman; Lisa A Cosimi; Michael Feldgarden; Andrew B Onderdonk; Bruce W Birren; Richard Platt; Susan S Huang Journal: J Infect Dis Date: 2013-09-16 Impact factor: 5.226